Google News has published a piece on what treatment options may be available to treat Lyme disease.

The article was originally published on February 16, 2017 and is currently up to date.

The article says a “Lyme disease Treatment Option” has been identified, and that the article states that it is a “research project and research collaboration with a major pharmaceutical company”.

“There are no clinical trials that have demonstrated the effectiveness of this treatment yet,” the article continues.

“There are currently no trials underway to evaluate the safety and efficacy of this Lyme disease Treatment option.”

Lyme is a severe disease caused by a bacterial infection.

It can be mild or severe, and symptoms can include fever, cough, chills, a sore throat and joint pain.

It’s caused by the Borrelia burgdorferi bacteria, a type of tick that lives in the tick-infested soil of many places around the world.

It can also be caused by another tick called the tapeworm.

The disease affects more than 100 million people around the globe.

The number of cases has tripled since 2014.

In 2016, there were more than 5 million confirmed cases worldwide.

“Lyme was once considered a rare and dangerous disease,” the paper states.

“Today, it is the third-most common cause of hospitalization in the United States, after HIV/AIDS and malaria.”

Since Lyme disease is so common, it often goes unreported, and the health care system often does not provide timely treatment for people with the disease,” it continues.”

There is also the stigma attached to the disease.

In some communities, it’s considered shameful to have a family member who is infected.

“As more people are diagnosed, we need to ensure that the treatment option for Lyme disease gets the attention it deserves,” the report concludes.

“With the continued increase in cases, it may be time to consider Lyme disease as a potential treatment option.”

Read more from our blog